PRLD - Prelude Therapeutics reports Q3 results
Prelude Therapeutics (PRLD): Q3 GAAP EPS of -$5.25.Cash and cash equivalents of $234.8M.Press Release.
For further details see:
Prelude Therapeutics reports Q3 resultsLink your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
| Company Name: | Prelude Therapeutics Incorporated |
| Stock Symbol: | PRLD |
| Market: | NASDAQ |
| Website: | preludetx.com |
Get PRLD Alerts
News, Short Squeeze, Breakout and More Instantly...